Rituximab in non-systemic vasculitic neuropathy: a single-center experience

DiscussionAnti-CD20 therapy might be an alternative in NSVN patients requiring further treatment escalation or treatment switch due to side effects of corticosteroids or cyclophosphamide.
Source: Journal of Neurology - Category: Neurology Source Type: research